In silico selection of therapeutic antibodies for development: Viscosity, clearance, and chemical stability

• Published in: Proceedings of the National Academy of Sciences - PNAS Vol. 111; no. 52; pp. 18601 - 18606
• Main Authors: Sharma, Vikas K., Patapoff, Thomas W., Kabakoff, Bruce, Pai, Satyan, Hilario, Eric, Zhang, Boyan, Li, Charlene, Borisov, Oleg, Kelley, Robert F., Chorny, Ilya, Zhou, Joe Z., Dill, Ken A., Swartz, Trevor E.
• Format: Journal Article
• Language: English
• Published: United States National Academy of Sciences 30.12.2014; National Acad Sciences
• Subjects: Amino acids; Animals; Antibodies; Antibodies, Monoclonal - chemistry; Antibodies, Monoclonal - therapeutic use; Biological Sciences; CHO Cells; Correlation analysis; Cricetinae; Cricetulus; Humans; Hydrophobicity; Immunoglobulin G - chemistry; Immunoglobulin G - therapeutic use; Isomerization; Isotypes; Medical treatment; Modeling; Molecules; Monoclonal antibodies; Oxidation; Physical properties; Protein Stability; Recombinant Proteins - chemistry; Recombinant Proteins - therapeutic use; Viscosity; pharmacokinetics; prediction; viscosity; degradation; monoclonal antibodies
• DOI: 10.1073/pnas.1421779112
• ISSN: 0027-8424

For mAbs to be viable therapeutics, they must be formulated to have low viscosity, be chemically stable, and have normal in vivo clearance rates. We explored these properties by observing correlations of up to 60 different antibodies of the IgG1 isotype. Unexpectedly, we observe significant correlations with simple physical properties obtainable from antibody sequences and by molecular dynamics simulations of individual antibody molecules. mAbs viscosities increase strongly with hydrophobicity and charge dipole distribution and decrease with net charge. Fast clearance correlates with high hydrophobicities of certain complementarity determining regions and with high positive or high negative net charge. Chemical degradation from tryptophan oxidation correlates with the average solvent exposure time of tryptophan residues. Aspartic acid isomerization rates can be predicted from solvent exposure and flexibility as determined by molecular dynamics simulations. These studies should aid in more rapid screening and selection of mAb candidates during early discovery. Significance mAbs are increasingly being used for treatment of chronic diseases wherein the subcutaneous delivery route is preferred to enable self-administration and at-home use. To deliver high doses (several hundred milligrams) through a small volume (∼1 mL) into the subcutaneous space, mAb solutions need to have low viscosity. Concomitantly, acceptable chemical stability is required for adequate shelf life, and normal in vivo clearance is needed for less frequent dosing. We propose in silico tools that provide rapid assessment of atypical behavior of mAbs (high viscosity, chemical degradation, and fast plasma clearance), which are simply predicted from sequence and/or structure-derived parameters. Such analysis will greatly improve the probability of success to move mAb-based therapeutics efficiently into clinical development and ultimately benefit patients.